Rashid, Nazia <br/><br/>
Real world treatment patterns in chronic myeloid leukemia patients newly initiated on tyrosine kinase inhibitors in an U.S. integrated healthcare system.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Jun 2018 
 - 253-263 p.  digital 
<br/><br/> Publication Type: Journal Article; Pragmatic Clinical Trial 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155217697484  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cohort Studies<br/>Dasatinib--therapeutic use<br/>Databases, Factual<br/>Delivery of Health Care, Integrated--methods<br/>Female<br/>Humans<br/>Imatinib Mesylate--therapeutic use<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyridines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Registries<br/>Retrospective Studies<br/>United States--epidemiology<br/>Young Adult